Doximity (DOCS) reported fiscal Q1 non-GAAP earnings Thursday of $0.36 per diluted share, up from $0.28 a year earlier.
Analysts polled by FactSet expected $0.30.
Revenue for the quarter ended June 30 was $145.9 million, up from $126.7 million a year earlier.
Analysts surveyed by FactSet expected $139.5 million.
The company expects fiscal Q2 revenue of $157 million to $158 million.
Analysts expect $150.2 million.
The company now expects fiscal 2026 revenue of $628 million to $636 million, up from the previous guidance of $619 million to $631 million.
Analysts surveyed by FactSet expect $626.5 million.
Separately, Doximity said Thursday it acquired Pathway Medical.
The deal closed on July 29 for a cash consideration of $26 million and up to $37 million in additional equity grants, according to the company.
Doximity shares were up nearly 7% in after-hours activity.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。